Shih-Yu Yu, Hao-Yi Li, Chi-Yun Wang, Wei-Jan Wang, Shih-Hao Hsu, Min-Chen Hsiang, Ke-Xin Yee, Kuen-Haur Lee and Yu-Cheng Lee (2025, Nov). Tumor-derived lactate fuels the STAT3-LCN2 pathway to promote bladder cancer malignancy and chemoresistance. Scientific Reports, 15:41610.
2025 JIF: 4.9 | Multidisciplinary Sciences: 21/140 (Q1)
Chih-Jie Shen, Hsien-Chung Chen, Chien-Liang Lin, Amandeep Thakur, Raphael Onuku, I-Chung Chen, Hao-Yi Li, Kwang-Yu Chang, Jian-Ying Chuang, Wen-Bin Yang, Hong-Yi Lin, Yi-Ru Shen, Jing-Ping Liou,* Wen-Chang Chang,* and Tsung-I Hsu* (2025, Jul). Contribution of Prostaglandin E2-Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood-Brain Barrier Crossing Celecoxib Derivative. Advanced Science, e06336.
2025 JIF: 14.1 | Chemistry, Multidisciplinary: 24/250 (Q1); Materials Science, Multidisciplinary: 46/472 (Q1); Nanoscience & Nanotechnology: 18/148 (Q1)
Yi-Ru Shen, Sofia Zaballa, Xavier Bech, Anna Sancho-Balsells, Irene Rodríguez-Navarro, Carmen Cifuentes-Díaz, Gönül Seyit-Bremer, Seung Hee Chun, Tobias Straub, Jordi Abante, Iñaki Merino, Laia Richard, Vipul Gupta, Hao-Yi Li, Ivan Ballasch, Noelia Alcázar, Jordi Alberch, Josep M Canals, Maria Abad, Manuel Serrano, Rüdiger Klein, Albert Giralt and Daniel del Toro (2024, Dec). Expansion of the neocortex and protection from neurodegeneration by in vivo transient reprogramming. Cell Stem Cell, 31, 1741-1759.
2025 JIF: 23.3 | Cell & Tissue Engineering: 1/32 (Q1); Cell Biology: 10/207 (Q1)
Pedro Weickert, Sophie Dürauer, Maximilian J. Götz, Hao-Yi Li, Julian Stingele (2024, Jun). Electro-elution-based purification of covalent DNA-protein cross-links. Nature Protocols , 19, 2891-2914.
2025 JIF: 18.4 | Biochemical Research Methods: 2/85 (Q1)
Christopher J Carnie, Maximilian J Götz, Chloe S Palma-Chaundler, Pedro Weickert, Amy Wanders, Almudena Serrano-Benitez, Hao-Yi Li, Vipul Gupta, Samah W Awwad, Christian J Blum, Matylda Sczaniecka-Clift, Jacqueline Cordes, Guido Zagnoli-Vieira, Giuseppina D’Alessandro, Sean L Richards, Nadia Gueorguieva, Simon Lam, Julian Stingele, and Stephen P Jackson (2024, May). Decitabine cytotoxicity is promoted by dCMP deaminase DCTD and mitigated by SUMO-dependent E3 ligase TOPORS. EMBO Journal , 43(12), 2397-2423.
2025 JIF: 8.4 | Biochemistry & Molecular Biology: 37/328 (Q1); Cell Biology: 38/207 (Q1)
Hao-Yi Li, Yin-Hsun Feng, Chien-Liang Lin, Tsung-I Hsu (2024, Mar). Mitochondrial Mechanisms in Temozolomide Resistance: Unraveling the Complex Interplay and Therapeutic Strategies in Glioblastoma. Mitochondrion, 75, 101836. 本人為第一作者
2025 JIF: 5.7 | Cell Biology: 66/207 (Q2); Genetics & Heredity: 30/192 (Q1)
Tzu-Jen Kao, Chien-Liang Lin, Wen-Bin Yang, Hao-Yi Li, Tsung-I Hsu (2023, Aug). Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities. Lipids in Health and Disease, 22, 114.
2025 JIF: 6.9 | Biochemistry & Molecular Biology: 49/328 (Q1); Nutrition & Dietetics: 15/114 (Q1)
Pedro Weickert, Hao-Yi Li, Maximilian J Götz, Sophie Dürauer, Denitsa Yaneva, Shubo Zhao, Jacqueline Cordes, Aleida C Acampora, Ignasi Forne, Axel Imhof, Julian Stingele (2023, Jan). SPRTN patient variants cause global-genome DNA-protein crosslink repair defects. Nature Communications, 14:352. 本人為第一作者
2025 JIF: 18.1 | Multidisciplinary Sciences: 8/140 (Q1)
Cheng-Han Lin, Wen-Der Lin, Yun-Chin Huang, Yu-Chia Chen, Zhu-Jun Loh, Luo-Ping Ger, Forn-Chia Lin, Hao-Yi Li, Hui-Chuan Cheng, Kuen-Haur Lee , Michael Hsiao, Pei-Jung Lu (2022, Nov). Carboxyl-terminal modulator protein facilitates tumor metastasis in triple-negative breast cancer. Cancer Gene Therapy.
2025 JIF: 6.4 | Biotechnology & Applied Microbiology: 27/180 (Q1); Genetics & Heredity: 21/192 (Q1); Medicine, Research & Experimental: 39/191 (Q1); Oncology: 59/333 (Q1)
Shubo Zhao, Anja Kieser, Hao-Yi Li, Hannah K Reinking, Pedro Weickert, Simon Euteneuer, Denitsa Yaneva, Aleida C Acampora, Maximilian J Götz, Regina Feederle, Julian Stingele (2021, Jan). A ubiquitin switch controls autocatalytic inactivation of the DNA-protein crosslink repair protease SPRTN. Nucleic Acids Research, 49, 902-915.
2025 JIF: 15.0 | Biochemistry & Molecular Biology: 14/328 (Q1)
Hannah K Reinking, Hyun-Seo Kang, Maximilian J Götz, Hao-Yi Li, Anja Kieser, Shubo Zhao, Aleida C Acampora, Pedro Weickert, Evelyn Fessler, Lucas T Jae, Michael Sattler, Julian Stingele (2020, Oct). DNA Structure-Specific Cleavage of DNA-Protein Crosslinks by the SPRTN Protease. Molecular Cell, 80, 102-113.
2025 JIF: 16.0 | Biochemistry & Molecular Biology: 12/328 (Q1); Cell Biology: 17/207 (Q1)
Cheng-Han Lin, Hao-Yi Li, Yu-Peng Liu, Pei-Fung Kuo, Wen-Ching Wang, Forn-Chia Lin, Wei-Lun Chang, Bor-Shyang Sheu, Yi-Ching Wang, Wan-Chun Hung, Hui-Chuan Cheng, Yun-Chin Yao, Marcus J Calkins, Michael Hsiao, Pei-Jung Lu (2019, Sep). High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma. Therapeutic Advances in Medical Oncology, 11,1758835919875324. 本人為第一作者
2025 JIF: 4.1 | Oncology: 111/333 (Q2)
Po-Shun Wang, Cheng-Han Chou, Cheng-Han Lin, Yun-Chin Yao, Hui-Chuan Cheng, Hao-Yi Li, Yu-Chung Chuang, Chia-Ning Yang, Luo-Ping Ger, Yu-Chia Chen, Forn-Chia Lin, Tang-Long Shen, Michael Hsiao, Pei-Jung Lu (2018, Aug). A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer. Oncogene, 37, 4662-4678.
2025 JIF: 9.1 | Biochemistry & Molecular Biology: 31/328 (Q1); Cell Biology: 33/207 (Q1); Genetics & Heredity: 11/192 (Q1); Oncology: 38/333 (Q1)
Hao-Yi Li, Jui-Lin Liang, Yao-Lung Kuo, Hao-Hsien Lee, Marcus J Calkins, Hong-Tai Chang, Forn-Chia Lin, Yu-Chia Chen, Tai-I Hsu, Michael Hsiao, Luo-Ping Ger, Pei-Jung Lu (2017, Dec). miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer. Breast Cancer Research, 19(1), 133. 本人為第一作者
2025 JIF: 6.2 | Oncology: 60/333 (Q1)
Yu-Chia Chen, Hao-Yi Li, Jui-Lin Liang, Luo-Ping Ger, Hong-Tai Chang, Michael Hsiao, Marcus J Calkins, Hui-Chuan Cheng, Jiin-Haur Chuang, Pei-Jung Lu (2016, Jul). CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient. Oncotarget, 8, 29699-29710.
2025 JIF / ranking: not provided in the supplied JCR export.
Cheng-Han Lin , Chen-Hsun Tsai, Ching-Tung Yeh, Jui-Lin Liang, Wan-Chun Hung, Forn-Chia Lin, Wei-Lun Chang, Hao-Yi Li, Yun-Chin Yao, Tai-I Hsu, Yu-Cheng Lee, Yi-Ching Wang, Bor-Shyang Sheu, Wu-Wei Lai, Marcus J Calkins, Michael Hsiao, Pei-Jung Lu (2016, May). MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma. Oncotarget, 7, 39680-39693.
2025 JIF / ranking: not provided in the supplied JCR export.
Hung-Yin Lin, Jian-Zhou Chen, Hao-Yi Li, Chia-Ning Yang (2015, Jun). A simple three-input DNA-based system works as a full-subtractor. Scientific Reports, 5, 10686.
2025 JIF: 4.9 | Multidisciplinary Sciences: 21/140 (Q1)
Cheng-Han Lin, Hao-Yi Li, Yu-Cheng Lee, Marcus J Calkins, Kuen-Haur Lee, Chia-Ning Yang, Pei-Jung Lu (2015, Feb). Landscape of Pin1 in the cell cycle. Experimental Biology and Medicine, 240, 403-408. 本人為第一作者
2025 JIF: 3.8 | Medicine, Research & Experimental: 72/191 (Q2)
Jen-Tai Lin, Hao-Yi Li, Nan-Shan Chang, Cheng-Han Lin, Yu-Chia Chen, Pei-Jung Lu (2015, Feb). WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phase. Cell Cycle, 14, 408-416. 本人為第一作者
2025 JIF: 3.9 | Cell Biology: 108/207 (Q3)
Shao-An Wang, Hao-Yi Li, Tsung-I Hsu, Shu-Hui Chen, Chin-Jen Wu, Wen-Chang Chang, Jan-Jong Hung (2011, Dec). Heat shock protein 90 stabilizes nucleolin to increase mRNA stability in mitosis. Journal of Biological Chemistry, 286, 43816-43829.
2025 JIF: 4.1 | Biochemistry & Molecular Biology: 130/328 (Q2)
Chih-Hua Tseng, Cherng-Chyi Tzeng, Chiao-Li Yang, Pei-Jung Lu, Hui-Ling Chen, Hao-Yi Li, You-Chung Chuang, Chia-Ning Yang, Yeh-Long Chen (2010, Aug). Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2. Journal of Medicinal Chemistry, 53, 6164-6179.
2025 JIF: 7.3 | Chemistry, Medicinal: 9/72 (Q1)
Arthur Y Shaw, Chun-Yi Chang, Hao-Han Liau, Pei-Jung Lu, Hui-Ling Chen, Chia-Ning Yang, Hao-Yi Li (2009, Jun). Synthesis of 2-styrylchromones as a novel class of antiproliferative agents targeting carcinoma cells. European Journal of Medicinal Chemistry, 44, 2552-2562.
2025 JIF: 6.7 | Chemistry, Medicinal: 11/72 (Q1)